Skip to content
DraconiticResearch
Search Sources API
190,332 studies31 sourcesUpdated 38 min ago
Peer-reviewedCC BY 4.0Frontiers in Bioengineering and Biotechnology

Beyond cell replacement: restoring organelle homeostasis as the next frontier of regenerative medicine

4 affiliations
  1. 1School of Medicine, Life and Health Sciences Research Institute (ICVS), University of Minho, Braga, Portugal
  2. 2ICVS/3B’s, PT Government Associate Laboratory, Guimarães, Portugal
  3. 3Department of Pharmacology, UCL School of Pharmacy, London, United Kingdom
  4. 4UCL Centre for Nerve Engineering, London, United Kingdom

Abstract

Neurodegenerative diseases (NDs) have traditionally been viewed as disorders driven by individual pathological processes, including protein aggregation, mitochondrial dysfunction, oxidative stress, endoplasmic reticulum (ER) stress, impaired autophagy, and neuroinflammation. However, growing evidence demonstrates that these mechanisms are not isolated events but interconnected manifestations of disrupted intracellular organelle communication. Dynamic interactions among mitochondria, the ER, lysosomes, peroxisomes, and other organelles coordinate calcium signaling, bioenergetics, proteostasis, lipid metabolism, and cellular stress adaptation, thereby preserving neuronal homeostasis. Progressive disruption of this communication network represents a fundamental driver of neuronal dysfunction and degeneration, suggesting that restoration of organelle homeostasis may constitute a more effective therapeutic strategy than targeting individual molecular pathways. In parallel, regenerative medicine has evolved beyond the concept of cell replacement toward approaches that enhance the resilience and repair capacity of surviving cells. Among these, mesenchymal stem cell (MSC)-derived secretomes and extracellular vesicles (EVs) have emerged as promising cell-free therapeutics owing to their diverse repertoire of proteins, lipids, metabolites, cytokines, growth factors, and regulatory RNAs capable of simultaneously modulating multiple cellular pathways. Accumulating evidence indicates that these bioactive cargos modulate mitochondrial function, alleviate ER stress, improve autophagy-lysosomal activity, reduce oxidative stress and neuroinflammation, and reinforce proteostasis, collectively promoting intracellular homeostasis. Here, we propose organelle homeostasis as a promising focus for regenerative medicine and discuss how cell-free therapies may redefine therapeutic strategies for NDs by restoring the intracellular communication networks that sustain cellular resilience. Finally, we highlight current translational challenges and future opportunities for engineering next-generation cell-free therapeutics targeting complex diseases.

Related

  1. Encapsulated mitochondrial transplantation: Advancing organelle therapeutics
    Hae-Jun Yang, Pil-Soo Jeong, Sun-Uk Kim
    Signal Transduction and Targeted TherapyPeer-reviewedCC BY-NC-ND 4.0Full textMolecular biology & gene regulationPMCEurope PMC
  2. Recent advances in organelle-targeted gene delivery technologies using nanomaterials
    Masaki Odahara, Keiji Numata
    Plant BiotechnologyPeer-reviewedCC BYFull textMolecular biology & gene regulationJ-STAGE
  3. How mitochondrial heterogeneity fuels a dynamic organelle ecosystem
    Pierre-Jean Desmaison, Giulia Bertolin
    Communications BiologyPeer-reviewedCC BY-NC-ND 4.0Full textMolecular biology & gene regulationHAL
  4. Lipid remodeling during phosphate starvation in plants: from metabolism to inter-organelle lipid transport
    Siqi Yan, Samia Alsayyad, Morgane Michaud
    BiochimiePeer-reviewedCC BY 4.0Full textEnzymology & metabolismHAL
  5. Organelle associations and metabolic rewiring of size-defined hepatic lipid droplets
    Qiumin Liao, Xiaochuan Fu, Yang Wang +8
    Communications BiologyPeer-reviewedCC BY 4.0Full textEnzymology & metabolismCrossref
BibTeX
@article{ferreiraantunes2026beyond,
  title = {{Beyond cell replacement: restoring organelle homeostasis as the next frontier of regenerative medicine}},
  author = {Filipa Ferreira-Antunes and Marta F. Lima and Anabela Moreira and Fernando J. Silva and Belém Sampaio-Marques and António J. Salgado},
  journal = {Frontiers in Bioengineering and Biotechnology},
  year = {2026},
  month = oct,
  doi = {10.3389/fbioe.2026.1953752},
  url = {https://doi.org/10.3389/fbioe.2026.1953752},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Beyond cell replacement: restoring organelle homeostasis as the next frontier of regenerative medicine
AU  - Filipa Ferreira-Antunes
AU  - Marta F. Lima
AU  - Anabela Moreira
AU  - Fernando J. Silva
AU  - Belém Sampaio-Marques
AU  - António J. Salgado
PY  - 2026
DA  - 2026/10/13
JO  - Frontiers in Bioengineering and Biotechnology
DO  - 10.3389/fbioe.2026.1953752
UR  - https://doi.org/10.3389/fbioe.2026.1953752
AB  - Neurodegenerative diseases (NDs) have traditionally been viewed as disorders driven by individual pathological processes, including protein aggregation, mitochondrial dysfunction, oxidative stress, endoplasmic reticulum (ER) stress, impaired autophagy, and neuroinflammation. However, growing evidence demonstrates that these mechanisms are not isolated events but interconnected manifestations of disrupted intracellular organelle communication. Dynamic interactions among mitochondria, the ER, lysosomes, peroxisomes, and other organelles coordinate calcium signaling, bioenergetics, proteostasis, lipid metabolism, and cellular stress adaptation, thereby preserving neuronal homeostasis. Progressive disruption of this communication network represents a fundamental driver of neuronal dysfunction and degeneration, suggesting that restoration of organelle homeostasis may constitute a more effective therapeutic strategy than targeting individual molecular pathways. In parallel, regenerative medicine has evolved beyond the concept of cell replacement toward approaches that enhance the resilience and repair capacity of surviving cells. Among these, mesenchymal stem cell (MSC)-derived secretomes and extracellular vesicles (EVs) have emerged as promising cell-free therapeutics owing to their diverse repertoire of proteins, lipids, metabolites, cytokines, growth factors, and regulatory RNAs capable of simultaneously modulating multiple cellular pathways. Accumulating evidence indicates that these bioactive cargos modulate mitochondrial function, alleviate ER stress, improve autophagy-lysosomal activity, reduce oxidative stress and neuroinflammation, and reinforce proteostasis, collectively promoting intracellular homeostasis. Here, we propose organelle homeostasis as a promising focus for regenerative medicine and discuss how cell-free therapies may redefine therapeutic strategies for NDs by restoring the intracellular communication networks that sustain cellular resilience. Finally, we highlight current translational challenges and future opportunities for engineering next-generation cell-free therapeutics targeting complex diseases.
SN  - 2296-4185
ER  -